The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Plant-based Vaccines Market Research Report 2024
Synopsis
The global Plant-based Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plant-based Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plant-based Vaccines.
Report Scope
The Plant-based Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plant-based Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plant-based Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biolabs
Medicago
iBio
ICON
EEA Consulting Engineers
Protalix
Kentucky BioProcessing
Segment by Type
Bacterial Vaccine
Viral Vaccine
Segment by Application
Anti-Infective
Anti-Cancer
Anti-Autoimmune Disease
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plant-based Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plant-based Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Plant-based Vaccines market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Plant-based Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Plant-based Vaccines.
Report Scope
The Plant-based Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Plant-based Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Plant-based Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Creative Biolabs
Medicago
iBio
ICON
EEA Consulting Engineers
Protalix
Kentucky BioProcessing
Segment by Type
Bacterial Vaccine
Viral Vaccine
Segment by Application
Anti-Infective
Anti-Cancer
Anti-Autoimmune Disease
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Plant-based Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Plant-based Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Plant-based Vaccines Market Overview
1.1 Product Overview and Scope of Plant-based Vaccines
1.2 Plant-based Vaccines Segment by Type
1.2.1 Global Plant-based Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 Bacterial Vaccine
1.2.3 Viral Vaccine
1.3 Plant-based Vaccines Segment by Application
1.3.1 Global Plant-based Vaccines Market Value by Application: (2024-2030)
1.3.2 Anti-Infective
1.3.3 Anti-Cancer
1.3.4 Anti-Autoimmune Disease
1.4 Global Plant-based Vaccines Market Size Estimates and Forecasts
1.4.1 Global Plant-based Vaccines Revenue 2019-2030
1.4.2 Global Plant-based Vaccines Sales 2019-2030
1.4.3 Global Plant-based Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Plant-based Vaccines Market Competition by Manufacturers
2.1 Global Plant-based Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Plant-based Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Plant-based Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Plant-based Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Plant-based Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Plant-based Vaccines, Product Type & Application
2.7 Plant-based Vaccines Market Competitive Situation and Trends
2.7.1 Plant-based Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Plant-based Vaccines Players Market Share by Revenue
2.7.3 Global Plant-based Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Plant-based Vaccines Retrospective Market Scenario by Region
3.1 Global Plant-based Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Plant-based Vaccines Global Plant-based Vaccines Sales by Region: 2019-2030
3.2.1 Global Plant-based Vaccines Sales by Region: 2019-2024
3.2.2 Global Plant-based Vaccines Sales by Region: 2025-2030
3.3 Global Plant-based Vaccines Global Plant-based Vaccines Revenue by Region: 2019-2030
3.3.1 Global Plant-based Vaccines Revenue by Region: 2019-2024
3.3.2 Global Plant-based Vaccines Revenue by Region: 2025-2030
3.4 North America Plant-based Vaccines Market Facts & Figures by Country
3.4.1 North America Plant-based Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Plant-based Vaccines Sales by Country (2019-2030)
3.4.3 North America Plant-based Vaccines Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Plant-based Vaccines Market Facts & Figures by Country
3.5.1 Europe Plant-based Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Plant-based Vaccines Sales by Country (2019-2030)
3.5.3 Europe Plant-based Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Plant-based Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Plant-based Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Plant-based Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Plant-based Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Plant-based Vaccines Market Facts & Figures by Country
3.7.1 Latin America Plant-based Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Plant-based Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Plant-based Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Plant-based Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Plant-based Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Plant-based Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Plant-based Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Plant-based Vaccines Sales by Type (2019-2030)
4.1.1 Global Plant-based Vaccines Sales by Type (2019-2024)
4.1.2 Global Plant-based Vaccines Sales by Type (2025-2030)
4.1.3 Global Plant-based Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Plant-based Vaccines Revenue by Type (2019-2030)
4.2.1 Global Plant-based Vaccines Revenue by Type (2019-2024)
4.2.2 Global Plant-based Vaccines Revenue by Type (2025-2030)
4.2.3 Global Plant-based Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Plant-based Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Plant-based Vaccines Sales by Application (2019-2030)
5.1.1 Global Plant-based Vaccines Sales by Application (2019-2024)
5.1.2 Global Plant-based Vaccines Sales by Application (2025-2030)
5.1.3 Global Plant-based Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Plant-based Vaccines Revenue by Application (2019-2030)
5.2.1 Global Plant-based Vaccines Revenue by Application (2019-2024)
5.2.2 Global Plant-based Vaccines Revenue by Application (2025-2030)
5.2.3 Global Plant-based Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Plant-based Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Creative Biolabs
6.1.1 Creative Biolabs Corporation Information
6.1.2 Creative Biolabs Description and Business Overview
6.1.3 Creative Biolabs Plant-based Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Creative Biolabs Plant-based Vaccines Product Portfolio
6.1.5 Creative Biolabs Recent Developments/Updates
6.2 Medicago
6.2.1 Medicago Corporation Information
6.2.2 Medicago Description and Business Overview
6.2.3 Medicago Plant-based Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Medicago Plant-based Vaccines Product Portfolio
6.2.5 Medicago Recent Developments/Updates
6.3 iBio
6.3.1 iBio Corporation Information
6.3.2 iBio Description and Business Overview
6.3.3 iBio Plant-based Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 iBio Plant-based Vaccines Product Portfolio
6.3.5 iBio Recent Developments/Updates
6.4 ICON
6.4.1 ICON Corporation Information
6.4.2 ICON Description and Business Overview
6.4.3 ICON Plant-based Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 ICON Plant-based Vaccines Product Portfolio
6.4.5 ICON Recent Developments/Updates
6.5 EEA Consulting Engineers
6.5.1 EEA Consulting Engineers Corporation Information
6.5.2 EEA Consulting Engineers Description and Business Overview
6.5.3 EEA Consulting Engineers Plant-based Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 EEA Consulting Engineers Plant-based Vaccines Product Portfolio
6.5.5 EEA Consulting Engineers Recent Developments/Updates
6.6 Protalix
6.6.1 Protalix Corporation Information
6.6.2 Protalix Description and Business Overview
6.6.3 Protalix Plant-based Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Protalix Plant-based Vaccines Product Portfolio
6.6.5 Protalix Recent Developments/Updates
6.7 Kentucky BioProcessing
6.6.1 Kentucky BioProcessing Corporation Information
6.6.2 Kentucky BioProcessing Description and Business Overview
6.6.3 Kentucky BioProcessing Plant-based Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Kentucky BioProcessing Plant-based Vaccines Product Portfolio
6.7.5 Kentucky BioProcessing Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Plant-based Vaccines Industry Chain Analysis
7.2 Plant-based Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Plant-based Vaccines Production Mode & Process
7.4 Plant-based Vaccines Sales and Marketing
7.4.1 Plant-based Vaccines Sales Channels
7.4.2 Plant-based Vaccines Distributors
7.5 Plant-based Vaccines Customers
8 Plant-based Vaccines Market Dynamics
8.1 Plant-based Vaccines Industry Trends
8.2 Plant-based Vaccines Market Drivers
8.3 Plant-based Vaccines Market Challenges
8.4 Plant-based Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Plant-based Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Plant-based Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Plant-based Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Plant-based Vaccines Sales (K Dose) of Key Manufacturers (2019-2024)
Table 5. Global Plant-based Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Plant-based Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Plant-based Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Plant-based Vaccines Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Plant-based Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Plant-based Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Plant-based Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Plant-based Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Plant-based Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Plant-based Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Plant-based Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Plant-based Vaccines Sales by Region (2019-2024) & (K Dose)
Table 18. Global Plant-based Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Plant-based Vaccines Sales by Region (2025-2030) & (K Dose)
Table 20. Global Plant-based Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Plant-based Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Plant-based Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Plant-based Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Plant-based Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Plant-based Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Plant-based Vaccines Sales by Country (2019-2024) & (K Dose)
Table 27. North America Plant-based Vaccines Sales by Country (2025-2030) & (K Dose)
Table 28. North America Plant-based Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Plant-based Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Plant-based Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Plant-based Vaccines Sales by Country (2019-2024) & (K Dose)
Table 32. Europe Plant-based Vaccines Sales by Country (2025-2030) & (K Dose)
Table 33. Europe Plant-based Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Plant-based Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Plant-based Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Plant-based Vaccines Sales by Region (2019-2024) & (K Dose)
Table 37. Asia Pacific Plant-based Vaccines Sales by Region (2025-2030) & (K Dose)
Table 38. Asia Pacific Plant-based Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Plant-based Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Plant-based Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Plant-based Vaccines Sales by Country (2019-2024) & (K Dose)
Table 42. Latin America Plant-based Vaccines Sales by Country (2025-2030) & (K Dose)
Table 43. Latin America Plant-based Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Plant-based Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Plant-based Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Plant-based Vaccines Sales by Country (2019-2024) & (K Dose)
Table 47. Middle East & Africa Plant-based Vaccines Sales by Country (2025-2030) & (K Dose)
Table 48. Middle East & Africa Plant-based Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Plant-based Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Plant-based Vaccines Sales (K Dose) by Type (2019-2024)
Table 51. Global Plant-based Vaccines Sales (K Dose) by Type (2025-2030)
Table 52. Global Plant-based Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Plant-based Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Plant-based Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Plant-based Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Plant-based Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Plant-based Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Plant-based Vaccines Price (US$/Dose) by Type (2019-2024)
Table 59. Global Plant-based Vaccines Price (US$/Dose) by Type (2025-2030)
Table 60. Global Plant-based Vaccines Sales (K Dose) by Application (2019-2024)
Table 61. Global Plant-based Vaccines Sales (K Dose) by Application (2025-2030)
Table 62. Global Plant-based Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Plant-based Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Plant-based Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Plant-based Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Plant-based Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Plant-based Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Plant-based Vaccines Price (US$/Dose) by Application (2019-2024)
Table 69. Global Plant-based Vaccines Price (US$/Dose) by Application (2025-2030)
Table 70. Creative Biolabs Corporation Information
Table 71. Creative Biolabs Description and Business Overview
Table 72. Creative Biolabs Plant-based Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Creative Biolabs Plant-based Vaccines Product
Table 74. Creative Biolabs Recent Developments/Updates
Table 75. Medicago Corporation Information
Table 76. Medicago Description and Business Overview
Table 77. Medicago Plant-based Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Medicago Plant-based Vaccines Product
Table 79. Medicago Recent Developments/Updates
Table 80. iBio Corporation Information
Table 81. iBio Description and Business Overview
Table 82. iBio Plant-based Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. iBio Plant-based Vaccines Product
Table 84. iBio Recent Developments/Updates
Table 85. ICON Corporation Information
Table 86. ICON Description and Business Overview
Table 87. ICON Plant-based Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. ICON Plant-based Vaccines Product
Table 89. ICON Recent Developments/Updates
Table 90. EEA Consulting Engineers Corporation Information
Table 91. EEA Consulting Engineers Description and Business Overview
Table 92. EEA Consulting Engineers Plant-based Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. EEA Consulting Engineers Plant-based Vaccines Product
Table 94. EEA Consulting Engineers Recent Developments/Updates
Table 95. Protalix Corporation Information
Table 96. Protalix Description and Business Overview
Table 97. Protalix Plant-based Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Protalix Plant-based Vaccines Product
Table 99. Protalix Recent Developments/Updates
Table 100. Kentucky BioProcessing Corporation Information
Table 101. Kentucky BioProcessing Description and Business Overview
Table 102. Kentucky BioProcessing Plant-based Vaccines Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Kentucky BioProcessing Plant-based Vaccines Product
Table 104. Kentucky BioProcessing Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Plant-based Vaccines Distributors List
Table 108. Plant-based Vaccines Customers List
Table 109. Plant-based Vaccines Market Trends
Table 110. Plant-based Vaccines Market Drivers
Table 111. Plant-based Vaccines Market Challenges
Table 112. Plant-based Vaccines Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Plant-based Vaccines
Figure 2. Global Plant-based Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Plant-based Vaccines Market Share by Type in 2023 & 2030
Figure 4. Bacterial Vaccine Product Picture
Figure 5. Viral Vaccine Product Picture
Figure 6. Global Plant-based Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Plant-based Vaccines Market Share by Application in 2023 & 2030
Figure 8. Anti-Infective
Figure 9. Anti-Cancer
Figure 10. Anti-Autoimmune Disease
Figure 11. Global Plant-based Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Plant-based Vaccines Market Size (2019-2030) & (US$ Million)
Figure 13. Global Plant-based Vaccines Sales (2019-2030) & (K Dose)
Figure 14. Global Plant-based Vaccines Average Price (US$/Dose) & (2019-2030)
Figure 15. Plant-based Vaccines Report Years Considered
Figure 16. Plant-based Vaccines Sales Share by Manufacturers in 2023
Figure 17. Global Plant-based Vaccines Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Plant-based Vaccines Players: Market Share by Revenue in 2023
Figure 19. Plant-based Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Plant-based Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Plant-based Vaccines Sales Market Share by Country (2019-2030)
Figure 22. North America Plant-based Vaccines Revenue Market Share by Country (2019-2030)
Figure 23. United States Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Plant-based Vaccines Sales Market Share by Country (2019-2030)
Figure 26. Europe Plant-based Vaccines Revenue Market Share by Country (2019-2030)
Figure 27. Germany Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Plant-based Vaccines Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Plant-based Vaccines Revenue Market Share by Region (2019-2030)
Figure 34. China Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. China Taiwan Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Plant-based Vaccines Sales Market Share by Country (2019-2030)
Figure 44. Latin America Plant-based Vaccines Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Plant-based Vaccines Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Plant-based Vaccines Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Plant-based Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Plant-based Vaccines by Type (2019-2030)
Figure 54. Global Revenue Market Share of Plant-based Vaccines by Type (2019-2030)
Figure 55. Global Plant-based Vaccines Price (US$/Dose) by Type (2019-2030)
Figure 56. Global Sales Market Share of Plant-based Vaccines by Application (2019-2030)
Figure 57. Global Revenue Market Share of Plant-based Vaccines by Application (2019-2030)
Figure 58. Global Plant-based Vaccines Price (US$/Dose) by Application (2019-2030)
Figure 59. Plant-based Vaccines Value Chain
Figure 60. Plant-based Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
